{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:08:48Z","timestamp":1777432128900,"version":"3.51.4"},"reference-count":243,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Ma 2528\/8-1"],"award-info":[{"award-number":["Ma 2528\/8-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-1525"],"award-info":[{"award-number":["SFB-1525"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H03405"],"award-info":[{"award-number":["19H03405"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology Plus"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jmccpl.2023.100036","type":"journal-article","created":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T02:07:37Z","timestamp":1683338857000},"page":"100036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Mechano-energetic uncoupling in hypertrophic cardiomyopathy: Pathophysiological mechanisms and therapeutic opportunities"],"prefix":"10.1016","volume":"4","author":[{"given":"Vasco","family":"Sequeira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark T.","family":"Waddingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotsugu","family":"Tsuchimochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Maack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James T.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2014","key":"10.1016\/j.jmccpl.2023.100036_bb0005","first-page":"2733","article-title":"ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb0010","first-page":"36","article-title":"The genetics of hypertrophic cardiomyopathy","volume":"2018","author":"Akhtar","year":"2018","journal-title":"Glob Cardiol Sci Pract"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0015","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJM200002103420609","article-title":"Sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Watkins","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/cvr\/cvv023","article-title":"Targets for therapy in sarcomeric cardiomyopathies","volume":"105","author":"Tardiff","year":"2015","journal-title":"Cardiovas Res"},{"issue":"5","key":"10.1016\/j.jmccpl.2023.100036_bb0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0168-9525(03)00081-7","article-title":"Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion","volume":"19","author":"Ashrafian","year":"2003","journal-title":"Trends Genet"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0030","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.CIR.102.8.858","article-title":"Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population","volume":"102","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0035","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12471-016-0943-2","article-title":"Life-long tailoring of management for patients with hypertrophic cardiomyopathy: awareness and decision-making in changing scenarios","volume":"25","author":"Michels","year":"2017","journal-title":"Neth Heart J"},{"issue":"1","key":"10.1016\/j.jmccpl.2023.100036_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001560","article-title":"Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity","volume":"8","author":"de Feria","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0050","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jacc.2005.04.062","article-title":"Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients","volume":"46","author":"Biagini","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jmccpl.2023.100036_bb0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCULATIONAHA.118.039132","article-title":"Higher body mass index in adolescence predicts cardiomyopathy risk in midlife","volume":"140","author":"Robertson","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb0060","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jjcc.2010.07.004","article-title":"Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based japanese population: results from Kochi RYOMA study","volume":"56","author":"Kubo","year":"2010","journal-title":"J Cardiol"},{"issue":"11","key":"10.1016\/j.jmccpl.2023.100036_bb0065","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1253\/jcj.63.859","article-title":"Gender differences in the presentation of adult obstructive hypertrophic cardiomyopathy with resting gradient a study of 122 patients","volume":"63","author":"Lin","year":"1999","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0070","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2005.04.043","article-title":"Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy","volume":"46","author":"Olivotto","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jmccpl.2023.100036_bb0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCGENETICS.111.960831","article-title":"Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy","volume":"5","author":"Page","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"6","key":"10.1016\/j.jmccpl.2023.100036_bb0080","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00424-014-1570-7","article-title":"Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice","volume":"467","author":"Najafi","year":"2014","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0085","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.112.270041","article-title":"Myofilament ca sensitization increases cytosolic ca binding affinity, alters intracellular ca homeostasis, and causes pause-dependent ca-triggered arrhythmia","volume":"111","author":"Schober","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0090","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/01.RES.0000059562.91384.1A","article-title":"Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling","volume":"92","author":"Knollmann","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0095","first-page":"1","article-title":"Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice","author":"Najafi","year":"2014","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0100","first-page":"H2414","article-title":"Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy","volume":"279","author":"Evans","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0105","first-page":"H705","article-title":"Ca2+ activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T","volume":"280","author":"Chandra","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0110","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/01.CIR.102.12.1346","article-title":"Tissue doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy","volume":"102","author":"Nagueh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1172\/JCI6067","article-title":"Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy","volume":"104","author":"Tardiff","year":"1999","journal-title":"J Clin Inv"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0120","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.yjmcc.2012.03.009","article-title":"Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of MYBPC3 mutation in heterozygous knock-in mice","volume":"52","author":"Fraysse","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0125","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1074\/jbc.M006745200","article-title":"Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy","volume":"276","author":"Knollmann","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0130","first-page":"H1780","article-title":"An \u03b1-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes","volume":"276","author":"Kim","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0135","first-page":"314","article-title":"Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy","volume":"2","author":"Ho","year":"2009","journal-title":"Circ Cardiovas Gen"},{"issue":"13","key":"10.1016\/j.jmccpl.2023.100036_bb0140","article-title":"How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness?Assessment with cardiovascular magnetic resonance","volume":"12","author":"Germans","year":"2010","journal-title":"J Cardiovas Mag Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/01.CIR.104.2.128","article-title":"Tissue doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy","volume":"104","author":"Nagueh","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0150","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.92.7.1680","article-title":"Hypertrophic cardiomyopathy. Clinical spectrum and treatment","volume":"92","author":"Wigle","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0155","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1161\/01.CIR.88.5.2206","article-title":"Regional left ventricular mechanics in hypertrophic cardiomyopathy","volume":"88","author":"Betocchi","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0160","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1161\/01.CIR.84.4.1496","article-title":"Left ventricular regional relaxation and its nonuniformity in hypertrophic nonobstructive cardiomyopathy","volume":"84","author":"Hayashida","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijcard.2013.10.059","article-title":"Patterns of cardiac dysfunction coinciding with exertional breathlessness in hypertrophic cardiomyopathy","volume":"170","author":"Maras","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0170","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1089\/ars.2017.7236","article-title":"Hypertrophic cardiomyopathy: a vicious cycle triggered by sarcomere mutations and secondary disease hits","volume":"31","author":"Wijnker","year":"2018","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0175","doi-asserted-by":"crossref","first-page":"E7003","DOI":"10.1073\/pnas.1513843112","article-title":"ADP-stimulated contraction: a predictor of thin-filament activation in cardiac disease","volume":"112","author":"Sequeira","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0180","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/CIRCRESAHA.111.300436","article-title":"Perturbed length-sependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations","volume":"112","author":"Sequeira","year":"2013","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jmccpl.2023.100036_bb0185","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/cvr\/cvv247","article-title":"Ranolazine antagonizes catecholamine-induced dysfunction in isolated cardiomyocytes, but lacks long-term therapeutic effects in vivo in a mouse model of hypertrophic cardiomyopathy","volume":"109","author":"Flenner","year":"2016","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0190","first-page":"H1720","article-title":"N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy","volume":"309","author":"Wilder","year":"2015","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0195","doi-asserted-by":"crossref","first-page":"187a","DOI":"10.1016\/j.bpj.2012.11.1056","article-title":"The HCM-associated cardiac troponin T mutation K280N increases the energetic cost of tension generation in human cardiac myofibrils","volume":"104","author":"Ferrara","year":"2013","journal-title":"Biophys J"},{"issue":"11","key":"10.1016\/j.jmccpl.2023.100036_bb0200","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/CIRCRESAHA.111.300436","article-title":"Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations","volume":"112","author":"Sequeira","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0205","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yjmcc.2020.10.006","article-title":"Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes","volume":"150","author":"Schuldt","year":"2021","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0210","article-title":"Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy","volume":"1","author":"Sequeira","year":"2022","journal-title":"J Mol Cell Cardiol Plus"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0215","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJM199204233261703","article-title":"Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy","volume":"326","author":"Watkins","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0220","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM199504203321603","article-title":"Mutations in the genes for cardiac troponin T and \u03b1-tropomyosin in hypertrophic cardiomyopathy","volume":"332","author":"Watkins","year":"1995","journal-title":"New Eng J Med"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0225","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/CIRCRESAHA.107.156380","article-title":"Dilated and hypertrophic cardiomyopathy mutations in troponin and \u03b1-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments","volume":"101","author":"Robinson","year":"2007","journal-title":"Circ Res"},{"issue":"43","key":"10.1016\/j.jmccpl.2023.100036_bb0230","doi-asserted-by":"crossref","first-page":"40710","DOI":"10.1074\/jbc.M203446200","article-title":"Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy","volume":"277","author":"Robinson","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yjmcc.2013.11.006","article-title":"Proteasomal and lysosomal protein degradation and heart disease","volume":"71","author":"Wang","year":"2014","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"10.1016\/j.jmccpl.2023.100036_bb0240","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ejhg.2013.16","article-title":"Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy","volume":"21","author":"Roncarati","year":"2013","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1016\/j.jmccpl.2023.100036_bb0245","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/ng.309","article-title":"A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia","volume":"41","author":"Dhandapany","year":"2009","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.jmccpl.2023.100036_bb0250","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCGENETICS.113.000448","article-title":"Sarcomere mutation-specific expression patterns in human hypertrophic cardiomyopathy","volume":"7","author":"Helms","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb0255","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/CIRCRESAHA.109.202440","article-title":"Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency","volume":"105","author":"Marston","year":"2009","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.jmccpl.2023.100036_bb0260","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/CIRCULATIONAHA.108.838672","article-title":"Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction","volume":"119","author":"van Dijk","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0265","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.yjmcc.2016.03.003","article-title":"Comparison of the effects of a truncating and a missense MYBPC3 mutation on contractile parameters of engineered heart tissue","volume":"97","author":"Wijnker","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0270","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijcard.2021.09.009","article-title":"Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy","volume":"344","author":"Hassoun","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0275","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0280","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(75)81040-4","article-title":"Correlation between contraction and phosphorylation of the inhibitory subunit of troponin in perfused rat heart","volume":"50","author":"England","year":"1975","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0285","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/262615a0","article-title":"Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart","volume":"262","author":"Solaro","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0290","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1139\/o86-086","article-title":"Phosphorylation of skeletal and cardiac muscle C-proteins by the catalytic subunit of cAMP-dependent protein kinase","volume":"64","author":"Lim","year":"1986","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0295","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/j.1460-2075.1995.tb07187.x","article-title":"Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction?","volume":"14","author":"Gautel","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0300","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/CIRCHEARTFAILURE.111.963702","article-title":"Contractile dysfunction irrespective of the mutant protein in human hypertrophic cardiomyopathy with normal systolic function","volume":"5","author":"van Dijk","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0305","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1113\/jphysiol.2006.107557","article-title":"Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts - role of myofilament Ca2+ sensitivity increase","volume":"575","author":"Sirenko","year":"2006","journal-title":"J Physiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0310","first-page":"H260","article-title":"Impact of site-specific phosphorylation of the protein kinase a sites ser23 and ser24 of cardiac troponin in human cardiomyocytes","volume":"304","author":"Wijnker","year":"2013","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0315","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0008-6363(02)00606-5","article-title":"Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins","volume":"57","author":"van der Velden","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0320","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/cvr\/cvw026","article-title":"Selective phosphorylation of PKA targets after \u03b2-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model","volume":"110","author":"Najafi","year":"2016","journal-title":"Cardiovas Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0325","first-page":"H151","article-title":"Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene","volume":"280","author":"Freeman","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0330","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1006\/jmcc.2001.1445","article-title":"A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice","volume":"33","author":"Prabhakar","year":"2001","journal-title":"J Mol Cell Cardiol"},{"issue":"33","key":"10.1016\/j.jmccpl.2023.100036_bb0335","doi-asserted-by":"crossref","first-page":"23097","DOI":"10.1074\/jbc.M114.561472","article-title":"Long term ablation of protein kinase a (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy","volume":"289","author":"Dweck","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0340","doi-asserted-by":"crossref","first-page":"15031","DOI":"10.1038\/ncomms15031","article-title":"FRET biosensor uncovers cAMP nano-domains at beta-adrenergic targets that dictate precise tuning of cardiac contractility","volume":"8","author":"Surdo","year":"2017","journal-title":"Nat Commun"},{"issue":"33","key":"10.1016\/j.jmccpl.2023.100036_bb0345","doi-asserted-by":"crossref","first-page":"20313","DOI":"10.1074\/jbc.272.33.20313","article-title":"Protein oxidation in aging, disease, and oxidative stress","volume":"272","author":"Berlett","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0350","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/10408398.2011.577540","article-title":"Protein oxidation: basic principles and implications for meat quality","volume":"53","author":"Zhang","year":"2013","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"5","key":"10.1016\/j.jmccpl.2023.100036_bb0355","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1096\/fj.201500048","article-title":"S-glutathiolation impairs phosphoregulation and function of cardiac myosin-binding protein C in human heart failure","volume":"30","author":"Stathopoulou","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0360","first-page":"H1344","article-title":"Oxidative stress in cardiomyocytes contributes to decreased SERCA2a activity in rats with metabolic syndrome","volume":"305","author":"Balderas-Villalobos","year":"2013","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0365","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/01.RES.78.6.1016","article-title":"Creatine kinase is the main target of reactive oxygen species in cardiac myofibrils","volume":"78","author":"Mekhfi","year":"1996","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jmccpl.2023.100036_bb0370","first-page":"15","article-title":"Protein oxidative modifications: beneficial roles in disease and health","volume":"1","author":"Cai","year":"2013","journal-title":"J Biochem Pharmacol Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0375","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fphar.2014.00224","article-title":"Protein redox chemistry: post-translational cysteine modifications that regulate signal transduction and drug pharmacology","volume":"5","author":"Wani","year":"2014","journal-title":"Front Pharmacol"},{"issue":"16","key":"10.1016\/j.jmccpl.2023.100036_bb0380","doi-asserted-by":"crossref","first-page":"12022","DOI":"10.1074\/jbc.M610363200","article-title":"The generation of the oxidized form of creatine kinase is a negative regulation on muscle creatine kinase*","volume":"282","author":"Zhao","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0385","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jsbmb.2014.12.011","article-title":"17beta-estradiol prevents cardiac diastolic dysfunction by stimulating mitochondrial function: a preclinical study in a mouse model of a human hypertrophic cardiomyopathy mutation","volume":"147","author":"Chen","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"10.1016\/j.jmccpl.2023.100036_bb0390","doi-asserted-by":"crossref","first-page":"H1237","DOI":"10.1152\/ajpheart.00727.2014","article-title":"Impaired cardiac mitochondrial oxidative phosphorylation and enhanced mitochondrial oxidative stress in feline hypertrophic cardiomyopathy","volume":"308","author":"Christiansen","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"10.1016\/j.jmccpl.2023.100036_bb0395","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.108.790501","article-title":"Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms","volume":"119","author":"Lombardi","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb0400","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/01.RES.0000177090.07296.ac","article-title":"Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy","volume":"97","author":"Senthil","year":"2005","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.jmccpl.2023.100036_bb0405","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.humpath.2015.07.017","article-title":"Increased oxidative stress contributes to cardiomyocyte dysfunction and death in patients with fabry disease cardiomyopathy","volume":"46","author":"Chimenti","year":"2015","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb0410","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1734-1140(09)70091-X","article-title":"Enhanced oxidative stress in hypertrophic cardiomyopathy","volume":"61","author":"Dimitrow","year":"2009","journal-title":"Pharmacol Rep"},{"issue":"6","key":"10.1016\/j.jmccpl.2023.100036_bb0415","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1253\/circj.70.710","article-title":"Nuclear hypertrophy reflects increased biosynthetic activities in myocytes of human hypertrophic hearts","volume":"70","author":"Koda","year":"2006","journal-title":"Circ J"},{"issue":"2","key":"10.1016\/j.jmccpl.2023.100036_bb0420","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cardfail.2004.05.005","article-title":"Relationship between oxidative stress and systolic dysfunction in patients with hypertrophic cardiomyopathy","volume":"11","author":"Nakamura","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0425","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1113\/jphysiol.2014.274571","article-title":"Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation","volume":"592","author":"Witjas-Paalberends","year":"2014","journal-title":"J Physiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0430","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/cvr\/cvu127","article-title":"Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations","volume":"103","author":"Witjas-Paalberends","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0435","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1172\/JCI1940","article-title":"Diastolic dysfunction and altered energetics in the alphaMHC403\/+ mouse model of familial hypertrophic cardiomyopathy","volume":"101","author":"Spindler","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0440","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1529\/biophysj.107.107557","article-title":"R-92L and R-92W mutations in cardiac troponin T lead to distinct energetic phenotypes in intact mouse hearts","volume":"93","author":"He","year":"2007","journal-title":"Biophys J"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0445","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/CIRCRESAHA.113.301055","article-title":"Focal energy deprivation underlies arrhythmia susceptibility in mice with calcium-sensitized myofilaments","volume":"112","author":"Huke","year":"2013","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.jmccpl.2023.100036_bb0450","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0735-1097(02)03009-7","article-title":"Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy","volume":"41","author":"Crilley","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jmccpl.2023.100036_bb0455","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005604","article-title":"Disease stage-dependent changes in cardiac contractile performance and oxygen utilization underlie reduced myocardial efficiency in human inherited hypertrophic cardiomyopathy","volume":"10","author":"G\u00fc\u00e7l\u00fc","year":"2017","journal-title":"Circ Cardiovasc Imag"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0460","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI15967","article-title":"Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T","volume":"112","author":"Javadpour","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0465","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0168-9525(03)00081-7","article-title":"Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion","volume":"19","author":"Ashrafian","year":"2003","journal-title":"Trends Genet"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0470","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/eurheartj\/16.suppl_O.115","article-title":"Contributions of 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease","volume":"16","author":"Neubauer","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0475","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1113\/jphysiol.2001.013478","article-title":"The creatine-phosphocreatine system: there's more than one song in its repertoire","volume":"537","author":"Greenhaff","year":"2001","journal-title":"J Physiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0480","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/CIRCULATIONAHA.106.613646","article-title":"Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium","volume":"114","author":"Smith","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0485","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.amjcard.2013.05.017","article-title":"Creatine kinase adenosine triphosphate and phosphocreatine energy supply in a single kindred of patients with hypertrophic cardiomyopathy","volume":"112","author":"Abraham","year":"2013","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.jmccpl.2023.100036_bb0490","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1074\/jbc.M006746200","article-title":"Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation","volume":"276","author":"Miller","year":"2001","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb0495","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/CIRCRESAHA.109.201251","article-title":"Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice","volume":"105","author":"Vignier","year":"2009","journal-title":"Circ Res"},{"issue":"13","key":"10.1016\/j.jmccpl.2023.100036_bb0500","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1074\/jbc.M006745200","article-title":"Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy","volume":"276","author":"Knollmann","year":"2001","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.jmccpl.2023.100036_bb0505","first-page":"3893","article-title":"Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice","volume":"118","author":"Baudenbacher","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0510","first-page":"H575","article-title":"Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy","volume":"284","author":"Lucas","year":"2003","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0515","first-page":"1853","article-title":"Relation of functional and morphological changes in mitochondria to myocardial contractile and relaxation reserves in asymptomatic to mildly symptomatic patients with hypertrophic cardiomyopathy","volume":"30","author":"Unno","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0520","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/eurheartj\/ehad028","article-title":"Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration","volume":"44","author":"Nollet","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0525","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1113\/JP270354","article-title":"Synergistic role of ADP and Ca2+ in diastolic myocardial stiffness","volume":"593","author":"Sequeira","year":"2015","journal-title":"J Physiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0530","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/CIRCRESAHA.118.310082","article-title":"Calcium signaling and reactive oxygen species in mitochondria","volume":"122","author":"Bertero","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0535","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmet.2015.07.008","article-title":"Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure","volume":"22","author":"Nickel","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0540","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jacc.2005.10.041","article-title":"AnAntifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation","volume":"47","author":"Marian","year":"2006","journal-title":"J Am Coll Cardio"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0545","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.108.790501","article-title":"Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms","volume":"119","author":"Lombardi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0550","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2008.02.048","article-title":"A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation","volume":"133","author":"Erickson","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0555","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/CIRCRESAHA.110.221911","article-title":"Reactive oxygen species-activated Ca\/calmodulin kinase II\u03b4 is required for late I(Na) augmentation leading to cellular Na and Ca overload","volume":"108","author":"Wagner","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0560","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cell.2008.04.041","article-title":"A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy","volume":"133","author":"Ago","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0565","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1161\/CIRCULATIONAHA.115.020086","article-title":"Genotype-dependent and -independent calcium signaling dysregulation in human hypertrophic cardiomyopathy","volume":"134","author":"Helms","year":"2016","journal-title":"Circulation"},{"issue":"1\u20134","key":"10.1016\/j.jmccpl.2023.100036_bb0570","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/biof.5520170128","article-title":"Redox signaling and the MAP kinase pathways","volume":"17","author":"Torres","year":"2003","journal-title":"Biofactors"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0575","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.cell.2016.04.002","article-title":"A tension-based model distinguishes hypertrophic versus dilated cardiomyopathy","volume":"165","author":"Davis","year":"2016","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.jmccpl.2023.100036_bb0580","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ejheart.2006.03.006","article-title":"Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a turkish family with a novel PRKAG2 mutation","volume":"8","author":"Bayrak","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0585","first-page":"284","article-title":"Activation of cardiac hypertrophic signaling pathways in a transgenic mouse with the human PRKAG2 Thr400Asn mutation","volume":"2010","author":"Banerjee","year":"1802","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0590","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0002-9149(96)00885-5","article-title":"Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III","volume":"79","author":"Lee","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0595","doi-asserted-by":"crossref","first-page":"12220","DOI":"10.1074\/jbc.M309773200","article-title":"Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398","volume":"279","author":"Browne","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0600","doi-asserted-by":"crossref","first-page":"32771","DOI":"10.1074\/jbc.M403528200","article-title":"Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte","volume":"279","author":"Chan","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0605","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0167-4889(89)90014-1","article-title":"The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase","volume":"1012","author":"Carling","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0610","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/diabetes.52.1.9","article-title":"Regulation of glycogen synthase by glucose and glycogen: a possible role for AMP-activated protein kinase","volume":"52","author":"Halse","year":"2003","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.jmccpl.2023.100036_bb0615","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0022-2828(75)90146-7","article-title":"Intramitochondrial glycogen deposits in hypertrophied human myocardium","volume":"7","author":"Maron","year":"1975","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb0620","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/01.CIR.50.3.436","article-title":"Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH)","volume":"50","author":"Maron","year":"1974","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb0625","first-page":"387","article-title":"Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy","volume":"79","author":"Maron","year":"1975","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.jmccpl.2023.100036_bb0630","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007022","article-title":"Proteomic and functional studies reveal detyrosinated tubulin as treatment target in sarcomere mutation-induced hypertrophic cardiomyopathy","volume":"14","author":"Schuldt","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0635","first-page":"H749","article-title":"AMPK attenuates microtubule proliferation in cardiac hypertrophy","volume":"304","author":"Fassett","year":"2013","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0640","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.freeradbiomed.2015.01.007","article-title":"The lipid peroxidation product 4-hydroxy-trans-2-nonenal causes protein synthesis in cardiac myocytes via activated mTORC1\u2013p70S6K\u2013RPS6 signaling","volume":"82","author":"Calamaras","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0645","first-page":"3893","article-title":"Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice","volume":"118","author":"Baudenbacher","year":"2008","journal-title":"J Clin Inv"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0650","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.112.134932","article-title":"Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy","volume":"27","author":"Coppini","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0655","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/01.RES.60.2.153","article-title":"Myocardial contractile function during ischemia and hypoxia","volume":"60","author":"Allen","year":"1987","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0660","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.hrthm.2011.08.007","article-title":"Gap junctions and conduction of cardiac excitation","volume":"8","author":"Kl\u00e9ber","year":"2011","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1016\/j.jmccpl.2023.100036_bb0665","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.RES.87.8.656","article-title":"Dephosphorylation and intracellular redistribution of ventricular Connexin43 during electrical uncoupling induced by ischemia","volume":"87","author":"Beardslee","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0670","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/01.RES.0000144805.11519.1e","article-title":"Reversible connexin 43 dephosphorylation during hypoxia and reoxygenation is linked to cellular ATP levels","volume":"95","author":"Turner","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0675","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00395-021-00900-9","article-title":"Cardiomyocyte Na+ and Ca2+ mishandling drives vicious cycle involving CaMKII, ROS, and ryanodine receptors","volume":"116","author":"Hegyi","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0680","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1172\/JCI26620","article-title":"Ca2+\/calmodulin-dependent protein kinase II regulates cardiac Na+ channels","volume":"116","author":"Wagner","year":"2006","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.jmccpl.2023.100036_bb0685","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.112.134932","article-title":"Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy","volume":"127","author":"Coppini","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0690","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/CIRCULATIONAHA.118.034549","article-title":"Chronic calmodulin-kinase II activation drives disease progression in mutation-specific hypertrophic cardiomyopathy","volume":"139","author":"Lehman","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0695","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0891-5849(96)00238-9","article-title":"Sarcoplasmic reticulum Ca2+-pump dysfunction in rat cardiomyocytes briefly exposed to hydroxyl radicals","volume":"22","author":"Morris","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0700","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1089\/ars.2012.4818","article-title":"Redox regulation of sodium and calcium handling","volume":"18","author":"Wagner","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0705","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.01775","article-title":"Redox dependent modifications of ryanodine receptor: basic mechanisms and implications in heart diseases","volume":"9","author":"Nikolaienko","year":"2018","journal-title":"Front Physiol"},{"issue":"12","key":"10.1016\/j.jmccpl.2023.100036_bb0710","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1161\/CIRCRESAHA.116.304691","article-title":"Mechanisms of sudden cardiac death: oxidants and metabolism","volume":"116","author":"Yang","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0715","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cvr\/cvm047","article-title":"Bidirectional regulation of Ca2+ sparks by mitochondria-derived reactive oxygen species in cardiac myocytes","volume":"77","author":"Yan","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0720","series-title":"Jahrestagung der Deutsche Gesellschaft f\u00fcr Kardiologie- Herz- und Kreislaufforschung vom 24. bis 27. April 2019 in Mannheim, Mannheim","article-title":"Mitochondrial redox mismatch and reactive oxygen species cause arrhythmias in hypertrophic cardiomyopathy","volume":"85","author":"Kohlhaas","year":"2019"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb0725","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.jmccpl.2023.100036_bb0730","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol Rev"},{"issue":"6","key":"10.1016\/j.jmccpl.2023.100036_bb0735","first-page":"e285","article-title":"Basics in clinical nutrition: metabolic response to hypoxia","volume":"3","author":"Fontaine","year":"2008","journal-title":"European e"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0740","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.2174\/138161208786071317","article-title":"Cardiac metabolism in myocardial ischemia","volume":"14","author":"Giuseppe","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0745","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.ph.36.030174.002213","article-title":"Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle","volume":"36","author":"Neely","year":"1974","journal-title":"Annu Rev Physiol"},{"issue":"7285","key":"10.1016\/j.jmccpl.2023.100036_bb0750","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"1","author":"Randle","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0755","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010926","article-title":"Metabolic changes in spontaneously hypertensive rat hearts precede cardiac dysfunction and left ventricular hypertrophy","volume":"8","author":"Li","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0760","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1161\/CIRCRESAHA.119.315483","article-title":"Metabolic remodeling promotes cardiac hypertrophy by directing glucose to aspartate biosynthesis","volume":"126","author":"Ritterhoff","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0765","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000441276","article-title":"Noninvasive detection of early metabolic left ventricular remodeling in systemic hypertension","volume":"133","author":"Hamirani","year":"2016","journal-title":"Cardiology"},{"issue":"11","key":"10.1016\/j.jmccpl.2023.100036_bb0770","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188479","article-title":"Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using 18F-fluorodeoxyglucose positron emission tomography","volume":"12","author":"Aoyama","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0775","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jacc.2011.05.018","article-title":"Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations","volume":"58","author":"Olivotto","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0780","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.yjmcc.2011.08.028","article-title":"The coronary circulation and blood flow in left ventricular hypertrophy","volume":"52","author":"Camici","year":"2012","journal-title":"J Mol Cell Cardiol"},{"issue":"18","key":"10.1016\/j.jmccpl.2023.100036_bb0785","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.106.657023","article-title":"Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging","volume":"115","author":"Petersen","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jmccpl.2023.100036_bb0790","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cvr\/cvv024","article-title":"Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations","volume":"105","author":"Olivotto","year":"2015","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.jmccpl.2023.100036_bb0795","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/jmcc.1996.0257","article-title":"Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy?","volume":"29","author":"Tanaka","year":"1997","journal-title":"J Mol Cell Cardio"},{"issue":"20","key":"10.1016\/j.jmccpl.2023.100036_bb0800","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1161\/CIRCULATIONAHA.114.011687","article-title":"Dietary fat supply to failing hearts determines dynamic lipid signaling for nuclear receptor activation and oxidation of stored triglyceride","volume":"130","author":"Lahey","year":"2014","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jmccpl.2023.100036_bb0805","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","article-title":"Metabolic remodelling in heart failure","volume":"15","author":"Bertero","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"11 Supplement","key":"10.1016\/j.jmccpl.2023.100036_bb0810","doi-asserted-by":"crossref","first-page":"A901","DOI":"10.1016\/S0735-1097(18)31442-6","article-title":"Different contribution of sarcomere and mitochondrial related gene mutations to hypertrophic cardiomyopathy","volume":"71","author":"Chung","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0815","first-page":"47","article-title":"Hypertrophic obstructive cardiomyopathy","volume":"116","author":"Batzner","year":"2019","journal-title":"Dtsch Arztebl Int"},{"issue":"10","key":"10.1016\/j.jmccpl.2023.100036_bb0820","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/hrt.2007.139535","article-title":"Acute effects of alcohol septal ablation on systolic and diastolic left ventricular function in patients with hypertrophic obstructive cardiomyopathy","volume":"94","author":"Steendijk","year":"2008","journal-title":"Heart"},{"issue":"25","key":"10.1016\/j.jmccpl.2023.100036_bb0825","first-page":"e558","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the american College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jmccpl.2023.100036_bb0830","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa025050","article-title":"Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy","volume":"349","author":"Cecchi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0835","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.105.603050","article-title":"Evidence of a dominant backward-propagating \"suction\" wave responsible for diastolic coronary filling in humans, attenuated in left ventricular hypertrophy","volume":"113","author":"Davies","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0840","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2019.03.059","article-title":"Left ventricular hypertrophy contributes to myocardial ischemia in non-obstructive coronary artery disease","volume":"286","author":"Eskerud","year":"2019","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.jmccpl.2023.100036_bb0845","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2559.2004.01835.x","article-title":"The pathology of hypertrophic cardiomyopathy","volume":"44","author":"Hughes","year":"2004","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb0850","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0735-1097(86)80181-4","article-title":"Intramural (\u201csmall vessel\u201d) coronary artery disease in hypertrophic cardiomyopathy","volume":"8","author":"Maron","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0855","series-title":"Hypertrophic Cardiomyopathy With extreme increase in left ventricular wall thickness: functional and morphologic features and clinical significance","first-page":"57","author":"Louie","year":"1986"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb0860","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1054-8807(03)00036-X","article-title":"Surgical pathology of subaortic septal myectomy associated with hypertrophic cardiomyopathy. A study of 204 cases (1996\u20132000)","volume":"12","author":"Lamke","year":"2003","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0865","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1136852","article-title":"Altered coronary artery function, arteriogenesis and endothelial YAP signaling in postnatal hypertrophic cardiomyopathy","volume":"14","author":"Langa","year":"2023","journal-title":"Front Physiol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0870","first-page":"H1171","article-title":"Length-dependent activation is modulated by cardiac troponin I bisphosphorylation at Ser23 and Ser24 but not by Thr143 phosphorylation","volume":"306","author":"Wijnker","year":"2014","journal-title":"Am J Physiol"},{"issue":"11","key":"10.1016\/j.jmccpl.2023.100036_bb0875","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11110787","article-title":"The echocardiographic parameters of systolic function are associated with specific metabolomic fingerprints in obstructive and non-obstructive hypertrophic cardiomyopathy","volume":"11","author":"Deidda","year":"2021","journal-title":"Metabolites"},{"issue":"8","key":"10.1016\/j.jmccpl.2023.100036_bb0880","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","article-title":"The failing heart relies on ketone bodies as a fuel","volume":"133","author":"Aubert","year":"2016","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jmccpl.2023.100036_bb0885","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure","volume":"133","author":"Bedi Kenneth","year":"2016","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jmccpl.2023.100036_bb0890","article-title":"Increased cardiac uptake of ketone bodies and free fatty acids in human heart failure and hypertrophic left ventricular remodeling","volume":"11","author":"Voros","year":"2018","journal-title":"Circulation"},{"issue":"6116","key":"10.1016\/j.jmccpl.2023.100036_bb0895","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1227166","article-title":"Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jmccpl.2023.100036_bb0900","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1080\/15592294.2015.1024406","article-title":"HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes","volume":"10","author":"Ooi","year":"2015","journal-title":"Epigenetics"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb0905","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome\u2013mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.jmccpl.2023.100036_bb0910","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/eurheartj\/ehab798","article-title":"Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction","volume":"43","author":"Butler","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jmccpl.2023.100036_bb0915","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123130","article-title":"SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms","volume":"4","author":"Osataphan","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0920","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1161\/CIRCULATIONAHA.109.934059","article-title":"Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy","volume":"122","author":"Abozguia","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0925","first-page":"9","article-title":"Changes in the cardiac metabolome caused by perhexiline treatment in a mouse model of hypertrophic cardiomyopathy","volume":"11","author":"Gehmlich","year":"2014","journal-title":"Mol Biosyst"},{"issue":"1","key":"10.1016\/j.jmccpl.2023.100036_bb0930","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/14756366.2011.636360","article-title":"NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation","volume":"28","author":"Gatto","year":"2013","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1\u20133","key":"10.1016\/j.jmccpl.2023.100036_bb0935","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2005.11.058","article-title":"Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation","volume":"531","author":"Kennedy","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"14","key":"10.1016\/j.jmccpl.2023.100036_bb0940","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/CIRCULATIONAHA.119.042770","article-title":"Myocardial energetics in obesity: enhanced ATP delivery through creatine kinase with blunted stress response","volume":"141","author":"Rayner","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jmccpl.2023.100036_bb0945","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jacc.2005.10.041","article-title":"Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation","volume":"47","author":"Marian","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jmccpl.2023.100036_bb0950","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.cellsig.2016.08.005","article-title":"Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophy","volume":"28","author":"Slone","year":"2016","journal-title":"Cell Signal"},{"issue":"6","key":"10.1016\/j.jmccpl.2023.100036_bb0955","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0891-5849(89)90066-X","article-title":"The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid","volume":"6","author":"Aruoma","year":"1989","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.jmccpl.2023.100036_bb0960","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s000180300001","article-title":"Molecular mechanisms of N-acetylcysteine actions","volume":"60","author":"Zafarullah","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0965","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1083\/jcb.201006159","article-title":"Making heads or tails of phospholipids in mitochondria","volume":"192","author":"Osman","year":"2011","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0970","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0005-2736(71)90123-4","article-title":"Enzymac characterization and lipid composition of rat liver subcellular membranes","volume":"249","author":"Colbeau","year":"1971","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0975","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0005-2736(90)90036-N","article-title":"Improved methods to isolate and subfractionate rat liver mitochondria. Lipid composition of the inner and outer membrane","volume":"1021","author":"Hovius","year":"1990","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"10.1016\/j.jmccpl.2023.100036_bb0980","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.cub.2009.10.074","article-title":"Mitochondrial cardiolipin involved in outer-membrane protein biogenesis: implications for Barth syndrome","volume":"19","author":"Gebert","year":"2009","journal-title":"Curr Biol"},{"issue":"8","key":"10.1016\/j.jmccpl.2023.100036_bb0985","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3109\/10715762.2012.676642","article-title":"Free radical oxidation of cardiolipin: chemical mechanisms, detection and implication in apoptosis, mitochondrial dysfunction and human diseases","volume":"46","author":"Yin","year":"2012","journal-title":"Free Radic Res"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0990","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/bph.12461","article-title":"First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics","volume":"171","author":"Szeto","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb0995","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.abb.2018.10.013","article-title":"Cardiolipin-targeted peptides rejuvenate mitochondrial function, remodel mitochondria, and promote tissue regeneration during aging","volume":"660","author":"Szeto","year":"2018","journal-title":"Arch Biochem Biophys"},{"issue":"8","key":"10.1016\/j.jmccpl.2023.100036_bb1000","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/bph.12468","article-title":"Targeting mitochondrial cardiolipin and the cytochrome c\/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis","volume":"171","author":"Birk","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jmccpl.2023.100036_bb1005","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1681\/ASN.2012121216","article-title":"The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin","volume":"24","author":"Birk","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl","key":"10.1016\/j.jmccpl.2023.100036_bb1010","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1016\/S0098-2997(97)00006-X","article-title":"Treatment of hypertrophic cardiomyopathy with coenzyme Q10","volume":"18","author":"Langsjoen","year":"1997","journal-title":"Mol Aspects Med"},{"issue":"1\u20134","key":"10.1016\/j.jmccpl.2023.100036_bb1015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/biof.5520320117","article-title":"Coenzyme Q10 (CoQ10) in isolated diastolic heart failure in hypertrophic cardiomyopathy (HCM)","volume":"32","author":"Adarsh","year":"2008","journal-title":"Biofactors"},{"issue":"580","key":"10.1016\/j.jmccpl.2023.100036_bb1020","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd7064","article-title":"Nicotinamide for the treatment of heart failure with preserved ejection fraction","volume":"13","author":"Abdellatif","year":"2021","journal-title":"Sci Transl Med"},{"issue":"21","key":"10.1016\/j.jmccpl.2023.100036_bb1025","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1161\/CIRCULATIONAHA.116.026099","article-title":"Nicotinamide riboside preserves cardiac function in a mouse model of dilated cardiomyopathy","volume":"137","author":"Diguet","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2023.100036_bb1030","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jmccpl.2023.100036_bb1035","doi-asserted-by":"crossref","first-page":"E8143","DOI":"10.1073\/pnas.1809540115","article-title":"Deciphering the super relaxed state of human \u03b2-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers","volume":"115","author":"Anderson","year":"2018","journal-title":"Proc Natl Acad Sci"},{"issue":"25","key":"10.1016\/j.jmccpl.2023.100036_bb1040","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.jacc.2021.09.1381","article-title":"Effect of mavacamten on echocardiographic features in symptomatic patients with obstructive hypertrophic cardiomyopathy","volume":"78","author":"Hegde","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jmccpl.2023.100036_bb1045","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCULATIONAHA.120.052359","article-title":"Mavacamten favorably impacts cardiac structure in obstructive hypertrophic cardiomyopathy: EXPLORER-HCM cardiac magnetic resonance substudy analysis","volume":"143","author":"Saberi","year":"2021","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.jmccpl.2023.100036_bb1050","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.jacc.2020.03.064","article-title":"Evaluation of mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy","volume":"75","author":"Ho","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"10253","key":"10.1016\/j.jmccpl.2023.100036_bb1055","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jmccpl.2023.100036_bb1060","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41569-022-00682-0","article-title":"Targeting the sarcomere in inherited cardiomyopathies","volume":"19","author":"Lehman","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"22","key":"10.1016\/j.jmccpl.2023.100036_bb1065","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2004840117","article-title":"Toward the correction of muscular dystrophy by gene editing","volume":"118","author":"Olson","year":"2021","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"10.1016\/j.jmccpl.2023.100036_bb1070","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41591-022-02176-5","article-title":"Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice","volume":"29","author":"Chai","year":"2023","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jmccpl.2023.100036_bb1075","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41591-022-02190-7","article-title":"Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice","volume":"29","author":"Reichart","year":"2023","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.jmccpl.2023.100036_bb1080","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007197","article-title":"Cardioprotective effects of Sirtuin-1 and its downstream effectors: potential role in mediating the heart failure benefits of SGLT2 (Sodium-glucose cotransporter 2) inhibitors","volume":"13","author":"Packer","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"16","key":"10.1016\/j.jmccpl.2023.100036_bb1085","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jmccpl.2023.100036_bb1090","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41569-020-0406-8","article-title":"SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control","volume":"17","author":"Cowie","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"22","key":"10.1016\/j.jmccpl.2023.100036_bb1095","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/CIRCULATIONAHA.121.053350","article-title":"Cardiac late Sodium Channel current is a molecular target for the Sodium\/Glucose cotransporter 2 inhibitor empagliflozin","volume":"143","author":"Philippaert","year":"2021","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.jmccpl.2023.100036_bb1100","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/CIRCULATIONAHA.121.057237","article-title":"Empagliflozin reverses late Na(+) current enhancement and cardiomyocyte proarrhythmia in a translational murine model of heart failure with preserved ejection fraction","volume":"145","author":"Hegyi","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jmccpl.2023.100036_bb1105","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ehf2.12336","article-title":"Empagliflozin reduces Ca\/calmodulin-dependent kinase II activity in isolated ventricular cardiomyocytes","volume":"5","author":"Mustroph","year":"2018","journal-title":"ESC Heart Failure"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb1110","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00125-016-4134-x","article-title":"Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+\/H+ exchanger in rats and rabbits","volume":"60","author":"Baartscheer","year":"2017","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb1115","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00125-017-4509-7","article-title":"Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na(+)\/H(+) exchanger, lowering of cytosolic Na(+) and vasodilation","volume":"61","author":"Uthman","year":"2018","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.jmccpl.2023.100036_bb1120","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/ehf2.13406","article-title":"Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure","volume":"8","author":"Hundertmark","year":"2021","journal-title":"ESC Heart Failure"},{"key":"10.1016\/j.jmccpl.2023.100036_bb1125","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00246-022-02846-8","article-title":"Longitudinal observational study of cardiac outcome risk factor prediction in children, adolescents, and adults with Barth syndrome","volume":"43","author":"Chowdhury","year":"2022","journal-title":"Pediatr Cardiol"},{"issue":"21","key":"10.1016\/j.jmccpl.2023.100036_bb1130","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1161\/CIRCULATIONAHA.121.053755","article-title":"Loss of mitochondrial Ca(2+) uniporter limits inotropic reserve and provides trigger and substrate for arrhythmias in Barth syndrome cardiomyopathy","volume":"144","author":"Bertero","year":"2021","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jmccpl.2023.100036_bb1135","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/CIRCRESAHA.119.315956","article-title":"AAV gene therapy prevents and reverses heart failure in a murine knockout model of Barth syndrome","volume":"126","author":"Wang","year":"2020","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb1140","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41436-020-01006-8","article-title":"A phase 2\/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism","volume":"23","author":"Reid Thompson","year":"2021","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.jmccpl.2023.100036_bb1145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jimd.12453","article-title":"Current and future treatment approaches for Barth syndrome","volume":"45","author":"Thompson","year":"2022","journal-title":"J Inherit Metab Dis"},{"issue":"50","key":"10.1016\/j.jmccpl.2023.100036_bb1150","doi-asserted-by":"crossref","first-page":"16684","DOI":"10.1021\/bi051908a","article-title":"Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction","volume":"44","author":"Han","year":"2005","journal-title":"Biochemistry"},{"issue":"21","key":"10.1016\/j.jmccpl.2023.100036_bb1155","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1021\/bi7004015","article-title":"Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study","volume":"46","author":"Han","year":"2007","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.jmccpl.2023.100036_bb1160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/01.RES.0000109416.56608.64","article-title":"Decrease in mitochondrial complex I activity in ischemic\/reperfused rat heart: involvement of reactive oxygen species and cardiolipin","volume":"94","author":"Paradies","year":"2004","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.jmccpl.2023.100036_bb1165","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.bbalip.2016.03.008","article-title":"Cardiac mitochondrial energy metabolism in heart failure: role of cardiolipin and sirtuins","volume":"1861","author":"Dolinsky","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.jmccpl.2023.100036_bb1170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.hfc.2021.07.004","article-title":"Hypertrophic cardiomyopathy in RASopathies: diagnosis, clinical characteristics, prognostic implications, and management","volume":"18","author":"Lioncino","year":"2022","journal-title":"Heart Fail Clin"},{"issue":"11","key":"10.1016\/j.jmccpl.2023.100036_bb1175","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3324\/haematol.2014.114595","article-title":"RAS diseases in children","volume":"99","author":"Niemeyer","year":"2014","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.jmccpl.2023.100036_bb1180","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI30756","article-title":"Mediating ERK 1\/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome","volume":"117","author":"Nakamura","year":"2007","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb1185","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1172\/JCI44929","article-title":"MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the raf 1(L613V) mutation","volume":"121","author":"Wu","year":"2011","journal-title":"J Clin Invest"},{"issue":"46","key":"10.1016\/j.jmccpl.2023.100036_bb1190","doi-asserted-by":"crossref","first-page":"16395","DOI":"10.1073\/pnas.1418126111","article-title":"K-RasV14I recapitulates Noonan syndrome in mice","volume":"111","author":"Hern\u00e1ndez-Porras","year":"2014","journal-title":"Proc Natl Acad Sci"},{"issue":"17","key":"10.1016\/j.jmccpl.2023.100036_bb1195","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.jacc.2019.01.066","article-title":"Hypertrophic cardiomyopathy in Noonan syndrome treated by MEK-inhibition","volume":"73","author":"Andelfinger","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jmccpl.2023.100036_bb1200","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/s41467-020-15505-4","article-title":"Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1\/2 signaling without cardiotoxic side-effects","volume":"11","author":"Tomasovic","year":"2020","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.jmccpl.2023.100036_bb1205","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","article-title":"Cardiac involvement in fabry disease: JACC review topic of the week","volume":"77","author":"Pieroni","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jmccpl.2023.100036_bb1210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijcard.2009.03.045","article-title":"Association between cardiac energy metabolism and gain of left ventricular mass in fabry disease","volume":"144","author":"Palecek","year":"2010","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.jmccpl.2023.100036_bb1215","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/eurjhf\/hfq211","article-title":"Cardiac energy metabolism is disturbed in fabry disease and improves with enzyme replacement therapy using recombinant human galactosidase A","volume":"13","author":"Machann","year":"2011","journal-title":"Eur J Heart Fail"}],"container-title":["Journal of Molecular and Cellular Cardiology Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772976123000065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772976123000065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:42:19Z","timestamp":1762648939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772976123000065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":243,"alternative-id":["S2772976123000065"],"URL":"https:\/\/doi.org\/10.1016\/j.jmccpl.2023.100036","relation":{},"ISSN":["2772-9761"],"issn-type":[{"value":"2772-9761","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechano-energetic uncoupling in hypertrophic cardiomyopathy: Pathophysiological mechanisms and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmccpl.2023.100036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100036"}}